Skip to content

Clinical trials

Terminated Neurodegenerative Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Terminated Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20071
20082
20141
20162
20175
20181
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Drexel University College of Medicine5
AstraZeneca2
Flex Pharma, Inc.2
AO Innovation Translation Center1
Alector Inc.1
Alzheimer's Disease Expert Lab (ADEL), Inc.1
Alzheon Inc.1
Genentech, Inc.1
Hoffmann-La Roche1
National Eye Institute (NEI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases19
Brain Diseases8
Nervous System Diseases8
Alzheimer Disease7
Amyotrophic Lateral Sclerosis7
Central Nervous System Diseases7
Dementia7
Movement Disorders7
Mental Disorders5
Motor Neuron Disease5

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.